NCT00279760 Phase I/II Multiple-Dose LEA29Y vs CTLAG4Ig vs Placebo in Rheumatoid Arthritis Status COMPLETED Phase PHASE1/PHASE2
NCT00279734 Vaccination Study of Abatacept (BMS-188667) for Normal Healthy Volunteers Status COMPLETED Phase PHASE1
NCT00269867 Infliximab Plus Methotrexate for the Treatment of Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT00267852 Study Evaluating the Clinical Remission in Early Aggressive Rheumatoid Arthritis Status COMPLETED Phase N/A
NCT00266227 A Study of Retreatment With Rituximab in Patients With Rheumatoid Arthritis Receiving Background Methotrexate Status COMPLETED Phase PHASE3
NCT00264550 An Efficacy and Safety Study of Golimumab in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy Status COMPLETED Phase PHASE3
NCT00264537 A Study of the Safety and Efficacy of Golimumab in Subjects With Rheumatoid Arthritis That Are Methotrexate-naive Status COMPLETED Phase PHASE3
NCT00264147 Rheumatoid Arthritis Dose Ranging Study (0663-086)(COMPLETED) Status COMPLETED Phase PHASE2
NCT00254293 Study to Assess Steady-State Trough Concentrations, Safety, and Immunogenicity of Abatacept After Subcutaneous (SC) Administration to Subjects With Rheumatoid Arthritis (RA) Status COMPLETED Phase PHASE1/PHASE2
NCT00252668 Study Evaluating the Combination of Etanercept and Methotrexate in Rheumatoid Arthritis Subjects Status COMPLETED Phase PHASE4
NCT00248105 Improving Motivation for Physical Activity in Arthritis Clinical Trial Status COMPLETED Phase NA
NCT00244556 Study Comparing Enbrel (Etanercept) Plus Methotrexate Versus Enbrel Alone in Active Rheumatoid Arthritis Despite Current Methotrexate Therapy Status COMPLETED Phase PHASE4
NCT00243412 A Study of the Safety and Efficacy of Rituximab in Patients With Moderate to Severe Rheumatoid Arthritis Receiving Methotrexate Status COMPLETED Phase PHASE2
NCT00242853 A Study To Investigate Markers Of Inflammation In Rheumatoid Arthritis Status COMPLETED Phase N/A
NCT00241982 Long-Circulating Liposomal Prednisolone Versus Pulse Intramuscular Methylprednisolone in Patients With Active Rheumatoid Arthritis Status COMPLETED Phase PHASE2